Structure-Activity Relationships and Ligand-Dependent Arrestin Bias in μ-Opioid Receptor-Mediated ERK Activation
Authors:
Open Access
- 30 April 2026
- journal article
- Published by The Korean Society of Applied Pharmacology in Biomolecules & Therapeutics
- Vol. 34 (3) , 556-564
Abstract
Lei Huang, Mengling Wang, Dooti Kundu, Suresh Paudel, Lulu Peng, Xinru Xian, Choon-Gon Jang and Kyeong-Man Kim. Biomolecules & Therapeutics 2026;34:556-64. https://doi.org/10.4062/biomolther.2025.255Keywords
Funding Information
- National Research Foundation of Korea (NRF-RS-2025-02304360)
- Ministry of Education (RS-2023-00239943)
- Ministry of Food and Drug Safety (23212MFDS218)
This publication has 25 references indexed in Scilit:
- Next generation of novel psychoactive substances on the horizon – A complex problem to faceDrug and Alcohol Dependence, 2015
- Structural insights into µ-opioid receptor activationNature, 2015
- Regulation of µ-Opioid Receptors: Desensitization, Phosphorylation, Internalization, and TolerancePharmacological Reviews, 2013
- Carfentanil—an ultra potent opioidThe American Journal of Emergency Medicine, 2010
- β-Arrestin-dependent, G Protein-independent ERK1/2 Activation by the β2 Adrenergic ReceptorJournal of Biological Chemistry, 2006
- Morphine Side Effects in β-Arrestin 2 Knockout MiceThe Journal of Pharmacology and Experimental Therapeutics, 2005
- μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependenceNature, 2000
- Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2Science, 1999
- Cloning and pharmacological characterization of a rat μ opioid receptorNeuron, 1993
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973